"My Body is One of the Best Commodities": Exploring the Ethics of Commodification in Phase I Healthy Volunteer Clinical Trials

Kennedy Institute of Ethics Journal 29 (4):305-331 (2019)
  Copy   BIBTEX

Abstract

In phase I clinical trials, healthy volunteers are dosed with investigational drugs and subjected to blood draws and other bodily monitoring procedures. In exchange, they are paid. Healthy volunteers are, in a very direct sense, selling access to their bodies for pharmaceutical companies and their associates to run drugs through. In his ethnographic study of socalled professional guinea pigs, Roberto Abadie writes, "Paid volunteers are well aware of the demand for an idealized, perfectly healthy volunteer. They also realize that their body is a valued commodity in clinical trials research". It is perhaps surprising, then, that commodification is little discussed in the bioethics literature on phase I...

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 76,168

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Healthy children as subjects in pharmaceutical research.Gideon Koren - 2003 - Theoretical Medicine and Bioethics 24 (2):149-159.

Analytics

Added to PP
2020-01-22

Downloads
11 (#845,481)

6 months
1 (#448,551)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

The ethical anatomy of payment for research participants.Joanna Różyńska - 2022 - Medicine, Health Care and Philosophy 25 (3):449-464.

Add more citations

References found in this work

No references found.

Add more references